Metrikler
Yayın
54
Açık Erişim
2
BM Sürdürülebilir Kalkınma Amaçları
Eğitim Bilgileri
1977 - 1981
1977 - 1981Tıpta Uzmanlık
Hacettepe Üniversitesi, Tıp Fakültesi, Türkiye
1971 - 1977
1971 - 1977Lisans
Hacettepe Üniversitesi, Tıp Fakültesi, Türkiye
Yönetimsel Görevler
2017 - Devam Ediyor
2017 - Devam EdiyorRektör
Hacettepe Üniversitesi, Rektörlük
2004 - 2011
2004 - 2011Anabilim/Bilim Dalı Başkanı
Hacettepe Üniversitesi, Tıp Fakültesi (İngilizce), Cerrahi Tıp Bilimleri Bölümü
1994 - 1996
1994 - 1996Dekan Yardımcısı
Hacettepe Üniversitesi, Tıp Fakültesi
Makaleler
Tümü (42)
SCI-E, SSCI, AHCI (41)
SCI-E, SSCI, AHCI, ESCI (42)
ESCI (1)
Scopus (35)
TRDizin (1)
2019
20191. Ga-68-labelled PSMA ligand HBED-CC PET/CT imaging in patients with recurrent prostate cancer
AKDEMİR E., TUNCEL M., AKYOL H. F., BİLEN C. Y., Baydar D. E., KARABULUT E., et al.
WORLD JOURNAL OF UROLOGY
, cilt.37, sa.5, ss.813-821, 2019 (SCI-Expanded, Scopus)
2017
20172. Polyethyleneimine brushes effectively inhibit encrustation on polyurethane ureteral stents both in dynamic bioreactor and in vivo
GULTEKINOGLU M., Kurum B., Karahan S., KART D., SAĞIROĞLU M., Ertas N., et al.
MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
, cilt.71, ss.1166-1174, 2017 (SCI-Expanded, Scopus)
2012
20123. Therapeutic effects of Mycobacterium phlei cell wall extracts
ORHAN B., BÜBER E., KESKIN M. S., ÇELİKBIÇAK Ö., SALİH B., ALP A., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES
, cilt.42, sa.2, ss.193-199, 2012 (SCI-Expanded, Scopus, TRDizin)
2012
20124. ADT for volume reduction, symptom relief and quality of life improvement in men with prostate cancer: Degarelix versus goserelin plus bicalutamide
Axcrona K., Aaltomaa S., Da Silva C. M., Ozen H., Damber J. E., Tanko L. B., et al.
EUROPEAN UROLOGY SUPPLEMENTS
, cilt.11, sa.1, 2012 (SCI-Expanded)
2010
20105. ROBOTIC RADIOSURGERY IN PROSTATE ADENOCARCINOMA: INITIAL THERAPEUTIC RESULTS AND QUALITY OF LIFE ASSESMENT
Akyol F., Ozyigit G., Sanli Y. T., Cengiz M., Akdogan B., YAZICI M. S., et al.
RADIOTHERAPY AND ONCOLOGY
, cilt.96, 2010 (SCI-Expanded, Scopus)
2010
20106. Can p53, Ki-67 and bcl-2 predict biochemical failure after radical prostatectomy?
Baseskioglu B., Akdogan B., Baydar D. E., Ozen H.
INDIAN JOURNAL OF UROLOGY
, cilt.26, sa.2, ss.206-212, 2010 (ESCI, Scopus)
2008
20087. Testicular teratoma and anti-N-methyl-D-aspartate receptor-associated encephalitis
Eker A., Saka E., Dalmau J., Kurne A., Bilen C., Ozen H., et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
, cilt.79, sa.9, ss.1082-1083, 2008 (SCI-Expanded, Scopus)
2008
20088. Is intermittent docetaxel chemotherapy reasonable in hormone refractory prostate cancer? A prospective randomised study
Akdogan B., Ozen H., Kirdal Y.
EUROPEAN UROLOGY SUPPLEMENTS
, cilt.7, sa.3, ss.231, 2008 (SCI-Expanded)
2007
20079. A new technique in the treatment of postprostatectomy incontinence: Adjustable male sling
Inci K., Ergen A., Yuksel S., Ozen H.
EUROPEAN UROLOGY SUPPLEMENTS
, cilt.6, sa.2, ss.76, 2007 (SCI-Expanded)
2007
200710. A cadaveric histological investigation of the prostate with three-dimensional reconstruction for better results in continence and erectile function after radical prostatectomy
Ozdemir M. B., Eskicorapci S. Y., Baydar D. E., Cumhur M., Onderoglu S., Ozen H.
PROSTATE CANCER AND PROSTATIC DISEASES
, cilt.10, sa.1, ss.77-81, 2007 (SCI-Expanded, Scopus)
2007
200711. Percutaneous nephrolithotomy in children: Two centers experience with 167 renal units
ŞAHİN A., Bilen C. Y., Inci K., Tan B., Eren M., Elhaj S., et al.
EUROPEAN UROLOGY SUPPLEMENTS
, cilt.6, sa.2, ss.243, 2007 (SCI-Expanded)
2006
200612. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: A prospective, randomized clinical trial
Divrik R., Yildirim U., Zorlu F., Ozen H.
JOURNAL OF UROLOGY
, cilt.175, sa.5, ss.1641-1644, 2006 (SCI-Expanded, Scopus)
2006
200613. Serum ribonuclease activity in the diagnosis of prostate cancer in men with serum prostate-specific antigen levels between 2.5 and 20 ng/mL
ESKICORAPCI S., Ozkara H. A., ONDER E., AKDOGAN B., ERKAN İ., CILIV G., et al.
CLINICAL BIOCHEMISTRY
, cilt.39, sa.4, ss.363-366, 2006 (SCI-Expanded, Scopus)
2005
200514. Low-grade Ta (noninvasive) urothelial carcinoma of the bladder
Oosterlinck W., Solsona E., Akaza H., Busch C., Goebell P., Malmstrom P., et al.
UROLOGY
, cilt.66, ss.75-89, 2005 (SCI-Expanded, Scopus)
2005
200515. Bilateral scrotal extra peritoneal herniation of ureters - Computed tomography urographic findings and review of the literature
Akpinar E., Turkbey B., Ozcan O., Akdogan B., KARÇAALTINCABA M., Ozen H.
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY
, cilt.29, sa.6, ss.790-792, 2005 (SCI-Expanded, Scopus)
2005
200516. Individualization of the biopsy protocol according to the prostate gland volume for prostate cancer detection
Eskicorapci S., Guliyev F., Akdogan B., Dogan H., Ergen A., Ozen H.
JOURNAL OF UROLOGY
, cilt.173, sa.5, ss.1536-1540, 2005 (SCI-Expanded, Scopus)
2005
200517. Complexed prostate specific antigen density is better than the other PSA derivatives for detection of prostate cancer in men with total PSA between 2.5 and 20 ng/ml: Results of a prospective multicenter study
Sozen S., Eskicorapci S., Kupelia B., Irkilata L., Altinel M., Ozer G., et al.
EUROPEAN UROLOGY
, cilt.47, sa.3, ss.302-307, 2005 (SCI-Expanded, Scopus)
2005
200518. Proliferating-cell nuclear antigen (PCNA) as an Independent prognostic marker in patients after prostatectomy: a comparison of PCNA and Ki-67
Taftachi R., Ayhan A., Ekici S., Ergen A., Ozen H.
BJU INTERNATIONAL
, cilt.95, sa.4, ss.650-654, 2005 (SCI-Expanded, Scopus)
2005
200519. Can we obtain better specimens with an end-cutting prostatic biopsy device?
Dogan H., Eskicorapci S., Ertoy-Baydar D., Akdogan B., Gunay L., Ozen H.
EUROPEAN UROLOGY
, cilt.47, sa.3, ss.297-301, 2005 (SCI-Expanded, Scopus)
2004
200420. CYP1A1 and GSTM1 polymorphic genotypes in patients with prostate cancer in a Turkish population
Aktas D., Hascicek M., Sozen S., Ozen H., Tuncbilek E.
CANCER GENETICS AND CYTOGENETICS
, cilt.154, sa.1, ss.81-85, 2004 (SCI-Expanded, Scopus)
2004
200421. Successful management of chromophobe type renal cell carcinoma in pregnancy
Guven S., Guven E., Islamoglu E., Gunalp G., Ozen H.
AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY
, cilt.44, sa.4, ss.362-363, 2004 (SCI-Expanded, Scopus)
2004
200422. Resection of pulmonary metastases following chemotherapy for high stage testicular tumors
Eskicorapci S., Ekici S., Atsu M., Dogan R., Ozen H.
International Journal of Urology
, cilt.11, sa.8, ss.634-639, 2004 (SCI-Expanded, Scopus)
2004
200423. An extended 10-core transrectal ultrasonography guided prostate biopsy protocol improves the detection of prostate cancer
Eskicorapci S., Baydar D., AKBAL C., Sofikerim M., Gunay M., Ekici S., et al.
EUROPEAN UROLOGY
, cilt.45, sa.4, ss.444-448, 2004 (SCI-Expanded, Scopus)
2003
200324. Urinary markers for urothelial cancer
Sozen S., Eskicorabci S., Ozen H.
BJU INTERNATIONAL
, cilt.92, sa.6, ss.531-533, 2003 (SCI-Expanded, Scopus)
2003
200325. The role of the pathologist in the evaluation of radical prostatectomy specimens
Ekici S., Ayhan A., Erkan I., Bakkaloglu M., Ozen H.
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY
, cilt.37, sa.5, ss.387-391, 2003 (SCI-Expanded, Scopus)
2003
200326. Prevalence of lower urinary tract symptoms in a community-based survey of men in Turkey
AKI F. T., Aygun C., Bilir N., Erkan I., Ozen H.
INTERNATIONAL JOURNAL OF UROLOGY
, cilt.10, sa.7, ss.364-370, 2003 (SCI-Expanded, Scopus)
2003
200327. A novel surveillance protocol for stage I nonseminomatous germ cell testicular tumours
Atsu N., Eskicorapci S., ÜNER A., Ekici S., Gungen Y., Erkan I., et al.
BJU INTERNATIONAL
, cilt.92, sa.1, ss.32-35, 2003 (SCI-Expanded, Scopus)
2003
200328. The predictive value of purified protein derivative results on complications and prognosis in patients with bladder cancer treated with bacillus Calmette-Guerin
Bilen C., Inci K., Erkan I., Ozen H.
JOURNAL OF UROLOGY
, cilt.169, sa.5, ss.1702-1705, 2003 (SCI-Expanded, Scopus)
2003
200329. Gynecomastia following chemotherapy for testicular cancer
Uygur M., Ozen H.
UROLOGIA INTERNATIONALIS
, cilt.70, sa.3, ss.253-254, 2003 (SCI-Expanded, Scopus)
2002
200230. Determination of prognosis in patients with prostate cancer treated with radical prostatectomy: Prognostic value of CD44v6 score
Ekici S., Ayhan A., Kendi S., Ozen H.
JOURNAL OF UROLOGY
, cilt.167, sa.5, ss.2037-2041, 2002 (SCI-Expanded, Scopus)
2002
200231. Surgical management of renal cell carcinoma with inferior vena cava tumor thrombus
Kaplan S., Ekici S., Dogan R., Demircin M., Ozen H., Pasaoglu I.
American Journal of Surgery
, cilt.183, sa.3, ss.292-299, 2002 (SCI-Expanded, Scopus)
2002
200232. False-positive results of the NMP22 test due to hematuria
Atsu N., Ekici S., Oge O., Ergen A., Hascelik G., Ozen H.
JOURNAL OF UROLOGY
, cilt.167, sa.2, ss.555-558, 2002 (SCI-Expanded, Scopus)
2002
200233. Microstaging of pT1 transitional cell carcinoma of the bladder - Does it really differentiate two populations with different prognoses? (pT1 subcategory)
Sozen S., AKBAL C., Sokmensuer C., Ekici S., Ozen H.
UROLOGIA INTERNATIONALIS
, cilt.69, sa.3, ss.200-206, 2002 (SCI-Expanded, Scopus)
2000
200034. Comparison of BTA stat and NMP22 tests in the detection of bladder cancer
Oge O., Atsu N., Sahin A., Ozen H.
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY
, cilt.34, sa.6, ss.349-351, 2000 (SCI-Expanded)
2000
200035. Is scrotal violation per se a risk factor for local relapse and metastases in stage I nonseminomatous testicular cancer?
Aki F., Bilen C., Tekin M., Ozen H.
UROLOGY
, cilt.56, sa.3, ss.459-462, 2000 (SCI-Expanded, Scopus)
2000
200036. A study of the etiology of idiopathic calcium urolithiasis in children: Hypocitruria is the most important risk factor
Tekin A., Tekgul S., Atsu N., Sahin A., Ozen H., Bakkaloglu M.
JOURNAL OF UROLOGY
, cilt.164, sa.1, ss.162-165, 2000 (SCI-Expanded, Scopus)
2000
200037. Bladder cancer
Ozen H., Hall M.
CURRENT OPINION IN ONCOLOGY
, cilt.12, sa.3, ss.255-259, 2000 (SCI-Expanded, Scopus)
2000
200038. Bilateral germ cell cancer of the testis: a report of 11 patients with a long-term follow-up
Tekin A., Aygun Y., Aki F., Ozen H.
BJU INTERNATIONAL
, cilt.85, sa.7, ss.864-868, 2000 (SCI-Expanded, Scopus)
2000
200039. Induction of mycobacteremia by intravesical bacillus Calmette-Guerin instillation in an experimental animal model and detection with polymerase chain reaction
Aygun C., Ozen H., Kocagoz T., Saribas Z., Aki T., Tekin I.
JOURNAL OF UROLOGY
, cilt.163, sa.5, ss.1588-1590, 2000 (SCI-Expanded, Scopus)
2000
200040. Proposal for changes in cystoscopic follow-up of patients with low-grade pTa gladder tumor
Oge O., Erdem E., Atsu N., Sahin A., Ozen H.
EUROPEAN UROLOGY
, cilt.37, sa.3, ss.271-273, 2000 (SCI-Expanded, Scopus)
2000
200041. Marsupialization for bilateral pararenal lymphatic cysts
Ekici S., Ziraman I., Ozen H., Erkan I.
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY
, cilt.34, sa.1, ss.77-78, 2000 (SCI-Expanded)
1990
199042. RETRIEVAL OF BROKEN DOUBLE-J CATHETER BY DORMIA BASKET
ERKAN I., SARIYUCE O., OZEN H.
BRITISH JOURNAL OF UROLOGY
, cilt.66, sa.1, ss.107-108, 1990 (SCI-Expanded)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler
2018
20181. Studies with some mycobacterial culture filtrates for immunotherapeutical activity
ERTÜRK Z., BÜBER E., ÖZEN A. H., ÇELİKBIÇAK Ö., SALİH B., AÇAN N. L.
22th ISE International ConferenceAll Aspects of Laboratory Medicine, 30 Haziran - 03 Temmuz 2018, (Özet Bildiri)
2017
20172. PROSTAT KANSERİNİN DEFİNİTİF TEDAVİSİ SONRASI REKÜRRENSİNDE GA-68-PSMA PET/BT POZİTİFLİK ORANI VE ETKİ EDEN FAKTÖRLER
AYDIN A. M., HABERAL H. B., Artykov M., AKDOĞAN B., GÜDELOĞLU A., BİLEN C. Y., et al.
13. Üroonkoloji Kongresi, Türkiye, 8 - 12 Kasım 2017
2017
20173. GA-68 PSMA PET/BT’xxNİN PROSTAT KANSERİ LENF NODU EVRELEMESİNDEKİ ETKİNLİĞİ: ERKEN DÖNEM SONUÇLAR
AYDIN A. M., HABERAL H. B., Artykov M., AKDOĞAN B., GÜDELOĞLU A., BİLEN C. Y., et al.
13. Üroonkoloji Kongresi, Türkiye, 8 - 12 Kasım 2017
2017
20174. Designing and Performance of Antibacterial Polymeric Brushed Ureteral Stents In-vivo
GULTEKINOGLU M., KART D., KÜRÜM B., AKSOY E. A., KARAHAN S., SAĞIROĞLU M., et al.
International Biomedical Science and Technology Symposium, Ankara, Türkiye, 12 - 14 Mayıs 2017, (Tam Metin Bildiri)
2017
20175. Metastatik kastrasyona dirençli prostat kanser hastalarında kabazitakselin güvenlik verileri: Kabazitaksel Türkiye insani amaçlı ilaca erişim programı sonuçları
BAVBEK S., BAŞARAN M., ÖZEN A. H., ERMAN M., ÖZDOĞAN M., ÖZGÜROĞLU M., et al.
22. ULUSAL KANSER KONGRESİ, Türkiye, 19 - 23 Nisan 2017, (Özet Bildiri)
2012
20126. TOLERABILITY OF CABAZITAXEL IN SENIOR ADULTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) IN EUROPE
Heidenreich A., Bracarda S., Mason M., Ozen H., Sengelov L., Gerritsen W., et al.
37th Congress of the European-Society-for-Medical-Oncology (ESMO), Vienna, Avusturya, 28 Eylül - 02 Ekim 2012, cilt.23, ss.307, (Özet Bildiri)
2012
20127. EFFICACY AND TOLERABILITY OF TAXANE-BASED CHEMOTHERAPY IN SENIOR ADULTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC): A PROSPECTIVE INTERNATIONAL REGISTRY
Droz J., Efstathiou E., Heidenreich A., Yildirim A., Cabrera P., Kim C., et al.
37th Congress of the European-Society-for-Medical-Oncology (ESMO), Vienna, Avusturya, 28 Eylül - 02 Ekim 2012, cilt.23, ss.308, (Özet Bildiri)
2008
20088. Incidence of EDNRB hypermethylation in prostatic adenocarcinoma
Baydar D. E., Himmetoglu C., Ozen H., De Marzo A. M.
97th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology, Colorado, Amerika Birleşik Devletleri, 1 - 07 Mart 2008, cilt.21, (Özet Bildiri)
2007
20079. Lymphovascular invasion in prostatic adenocarcinoma
Ertoy-Baydar D., Baseskioglu B., Ozen H., Geyik P.
96th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology, California, Amerika Birleşik Devletleri, 24 - 30 Mart 2007, cilt.20, (Özet Bildiri)
2007
200710. Immunohistochemical analysis of PTEN expression in radical prostatectomies
Ertoy-Baydar D., Ozen H., Saracbasi O., De Marzo A. M.
96th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology, California, Amerika Birleşik Devletleri, 24 - 30 Mart 2007, cilt.87, (Özet Bildiri)
2007
200711. Telomere shortening correlates with short relapse-free survival time in prostate adenocarcinoma
Ertoy-Baydar D., Ozen H., Gurel B., Saracbasi O., Geyik P., De Marzo A. M.
96th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology, California, Amerika Birleşik Devletleri, 24 - 30 Mart 2007, cilt.20, (Özet Bildiri)